Alector, Inc. (ALEC) Q2 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Alector, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.089 -- 00:00:04.571 Ladies and gentlemen, and welcome to the Alcator Mid-Year 2023 00:00:04.571 -- 00:00:10.174 Earnings Conference Call. At this time, all participants are in a listen-only mode. 00:00:10.174 -- 00:00:14.557 After the speaker's presentation, there will be a question and answer session. 00:00:14.557 -- 00:00:19.580 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:19.580 -- 00:00:23.782 You will then hear an automated message advising your hand is raised. 00:00:23.782 -- 00:00:28.343 To withdraw your question, please press star 11 again. 00:00:28.394 -- 00:00:31.657 As a reminder, this conference call is being recorded. 00:00:31.657 -- 00:00:36.701 I would now like to turn the call over to Katie Hogan, Senior Director 00:00:36.701 -- 00:00:39.123 of Corporate Communication 00:00:39.123 -- 00:00:42.546 and Investor Relations. Please go ahead. 00:00:42.546 -- 00:00:44.546 Thank 00:00:46.269 -- 00:00:48.931 you, Operator, and good afternoon, everyone. 00:00:48.931 -- 00:00:54.366 Earlier this afternoon, we released our financial results for the second quarter of 2023. 00:00:54.366 -- 00:00:59.307 The press release is available on our website at www.elector.com. 00:01:00.308 -- 00:01:05.409 And our 10-Q is filed with the Securities and Exchange Commission this afternoon. 00:01:05.490 -- 00:01:10.592 Joining me on the call today are Dr. Arnon Rosenthal, co-founder and CEO, 00:01:10.592 -- 00:01:15.613 Dr. Sarah Kankari Mitra, President and Head of Research and Development, Dr. 00:01:15.613 -- 00:01:19.115 Gary Romano, Chief Medical Officer, and Dr. 00:01:19.115 -- 00:01:24.280 Mark Grasso, Chief Financial Officer. After our formal remarks, we'll open 00:01:24.280 -- 00:01:28.863 the call for Q&A. ...